PET-scan in colorectal cancer

Acta Chir Belg. 2005 Aug;105(4):333-7. doi: 10.1080/00015458.2005.11679732.

Abstract

After an introduction on the physical and biological basics of positron emission tomography, this paper reviews the current status of PET imaging using the glucose analogue FDG in colorectal cancer. The use of PET-FDG is reviewed for detection, initial staging, therapy monitoring and staging of disease relapse.

Publication types

  • Review

MeSH terms

  • Colorectal Neoplasms / diagnostic imaging*
  • Colorectal Neoplasms / metabolism
  • Colorectal Neoplasms / pathology
  • Fluorodeoxyglucose F18
  • Glucose / metabolism
  • Humans
  • Neoplasm Recurrence, Local / diagnosis
  • Neoplasm Staging
  • Positron-Emission Tomography*
  • Radiopharmaceuticals

Substances

  • Radiopharmaceuticals
  • Fluorodeoxyglucose F18
  • Glucose